Dr. Glenn Lopez administered a standard test for the coronavirus to Daniel Contreras at a mobile clinic in South Los Angeles last week. Though highly accurate, such tests can take days or more to process. Mario Tama/Getty Images hide caption
Dr. Glenn Lopez administered a standard test for the coronavirus to Daniel Contreras at a mobile clinic in South Los Angeles last week. Though highly accurate, such tests can take days or more to process.
Anybody who has waited for hours in line for a coronavirus test, or who has had to wait a week or more for results, knows there has to be a better way. In fact, the next generation of tests will focus on speed.
But what should the Food and Drug Administration do with a rapid test that is comparatively cheap but much less accurate than the tests currently on the market? A test like that is ready to go up for FDA approval, and some scientists argue it could be valuable despite its shortcomings.
At first blush, you wouldn't want a medical test to be pushing out untrustworthy results. And that's certainly the case for a medical diagnosis. But rapid test could be valuable if used to screen large numbers of people for infection repeatedly and frequently.
For example, some of the rapid tests under development don't detect the virus in a person who is in the early or late stages of infection they only catch an infection at its peak. Dr. Michael Mina at the Harvard T.H. Chan School of Public Health says that's OK, under certain circumstances.
"As long as you're using the test on a pretty frequent basis," Mina says, "you will be more likely than not to catch the person on the day they might go out and transmit. And they'll know to stay home."
To be useful, such tests need to be widely available and affordable, he says. "I envision a time when everyone can order a pack of 50 tests for $50 and have those and use them every other day for a couple of months."
When it comes to controlling the epidemic, that could be an appealing alternative to the current laboratory-based system, an overburdened process that has become a serious bottleneck. These days, some people are waiting a week or more for results, and by then they have potentially spread the virus to others.
Highly accurate at-home tests are probably many months away. But Mina argues they could be here sooner if the FDA would not demand that tests for the coronavirus meet really high accuracy standards of 80 percent or better.
A Massachusetts-based startup called E25Bio has developed this sort of rapid test. Founder and Chief Technology Officer Irene Bosch says her firm has field-tested it in hospitals. "What we learned is that the test is able to be very efficient for people who have a lot of virus," she says.
It's nowhere near as good at detecting low levels of virus. But you can have the most sensitive test in the world, she says, and if you only test people once a month, that test, too, will miss a lot of people who are infected. So, her company is focusing on quick, easy and cheap.
"These are very simple strips," she says. "They're [like] miniaturized pregnancy tests. So, you can imagine you can't find anything more simple than this."
The sample for this test would come via a swab of the nose or mouth. Results would be available within 15 minutes, according to the manufacturer. Most important is the price.
"The test has to be affordable. It cannot work if it's not affordable," Bosch says. "Right now it might cost $3 to make it [or] $4 to make it. So affordable will be what it costs."
E25Bio would like to set the price at cost, though for the start-up company to stay in business, Bosch says, the test would need a government subsidy. The company has a local partner that's poised to produce a million of these tests a week, she says, adding that another company in the United Kingdom is poised to produce 8 million tests a day.
E25Bio has asked the governor of Massachusetts to approve the rapid test for sale not for use at home just yet, but in pharmacies and out in the community.
To bring people back to work, or teachers and students back to the classroom safely, "this is the kind of test you need," Bosch says.
The company would like to pair the test with a smartphone app. The app would take a photo of the test result and upload it to a public database. The information would be stripped of personal details and precise location, but if people volunteered to take this step, she says, the public could crowdsource information about the spread of the coronavirus that would be useful to researchers. The information would also be available to public health authorities.
The company is in talks with the FDA about approving this test, even though it would be a departure for the federal agency, which has so far required a higher level of accuracy.
She isn't sure how the FDA is responding to the company's request. "This is a Pandora's box and this like is a black box," she says with a laugh.
In other words, the FDA doesn't want to take an action that backfires, and it also doesn't tend to reveal its thinking as it deliberates. The FDA told NPR that the agency weighs the benefits and risks of all coronavirus tests, but didn't elaborate on its thinking about this novel testing strategy.
"There's always a tradeoff here. There's no free lunch," says Trevor Martin, chief executive officer of the Bay Area biotech startup, Mammoth Biosciences. His company is also making a rapid test, based on the gene-editing technology CRISPR. Though CRISPR is best known for its ability to edit DNA, part of that process involves pinpointing specific sequences. And by targeting the coronavirus' genetic sequence, this approach can be highly accurate, he says.
"Our goal is to have a test that delivers extremely high-quality results with a single test. The same as you would get in a lab, or better," Martin says.
His company's test isn't likely to be on the market until the end of the year, which seems like the distant future, considering the pace of the epidemic. He agrees tests need to be affordable, but he didn't name a price range for the test.
Martin says precision has a place in controlling the epidemic, too. A test that can detect very low levels of virus is more likely to pick up someone with a mild infection, even in the absence of symptoms. And that's "super important if you want to prevent spread," he says.
Other labs are pursuing tests based on CRISPR as well. And two companies have temporary approval by the FDA to sell a rapid test that detects certain proteins antigens from the coronavirus. These antigen tests are less accurate than the standard PCR tests, which detect genetic material from the virus. The average wholesale price for antigen tests is in the $20 range. Such tests are currently in limited supply, and available at hospitals, medical clinics and some doctor's offices.
It's unlikely that there will be one single testing solution for the coronavirus, and the best blend of approaches is still a work in progress.
You can contact NPR Science Correspondent Richard Harris at rharris@npr.org.
See original here:
How An At-Home Test For COVID-19 Could Help Control The Pandemic : Shots - Health News - NPR
- 2024 CDC COVID-19 guidelines: Isolation, masks, what you should know - The Arizona Republic - February 29th, 2024 [February 29th, 2024]
- Long Covid and Impaired Cognition More Evidence and More Work to Do | NEJM - nejm.org - February 29th, 2024 [February 29th, 2024]
- Prospective Memory Assessment before and after Covid-19 | NEJM - nejm.org - February 29th, 2024 [February 29th, 2024]
- A pandemic that won't go away as COVID enters its 5th year, NZ needs a realistic strategy - The Conversation - February 29th, 2024 [February 29th, 2024]
- Older US adults should get another COVID-19 shot, advisers say - Detroit News - February 29th, 2024 [February 29th, 2024]
- Vaping increases susceptibility to COVID-19 infection, study finds - News-Medical.Net - February 29th, 2024 [February 29th, 2024]
- Older U.S. adults should get another covid-19 shot, advisers say - TribLIVE - February 29th, 2024 [February 29th, 2024]
- Vapers More Susceptible to COVID-19 Infection Than Tobacco Smokers, Reveals Study | Weather.com - The Weather Channel - February 29th, 2024 [February 29th, 2024]
- How we met: She was in the next hospital bed and I loved her accent - The Guardian - February 29th, 2024 [February 29th, 2024]
- Fleet To Hit Record Size In 2024 But Still Suffering Covid Hangover - Forbes - February 29th, 2024 [February 29th, 2024]
- How vaccine hesitancy is contributing to rising rates of measles and COVID - PBS NewsHour - February 29th, 2024 [February 29th, 2024]
- How did COVID-19 impact cancer incidence trends in the US? - News-Medical.Net - February 29th, 2024 [February 29th, 2024]
- CT-based Assessment at 6-Month Follow-up of COVID-19 Pneumonia patients in China | Scientific Reports - Nature.com - February 29th, 2024 [February 29th, 2024]
- Covid in 2024: What to Know About Guidelines, Symptoms and Vaccines - WSJ - The Wall Street Journal - February 29th, 2024 [February 29th, 2024]
- Unlocking coronavirus structure through M protein research - News-Medical.Net - February 29th, 2024 [February 29th, 2024]
- SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- People 65 and up should now get another COVID-19 vaccine, CDC recommends - cleveland.com - February 29th, 2024 [February 29th, 2024]
- Welcome to the 2024 CFA Annual Report | Covid-19 | news-journal.com - Longview News-Journal - February 29th, 2024 [February 29th, 2024]
- Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national ... - Nature.com - February 29th, 2024 [February 29th, 2024]
- R.I. COVID-19 cases increased by 337 last week, with 2 deaths - Providence Business News - February 29th, 2024 [February 29th, 2024]
- Older US adults should get another COVID-19 shot, advisers say - NBC Bay Area - February 29th, 2024 [February 29th, 2024]
- Cognitive Deficits Seen in COVID-19 Patients Regardless of Symptom Duration - HealthDay - February 29th, 2024 [February 29th, 2024]
- CDC recommends seniors get another Covid-19 shot - Baltimore Sun - February 29th, 2024 [February 29th, 2024]
- Odds of Severe COVID-19 High for Hematologic Cancer Patients During Pandemic - HealthDay - February 29th, 2024 [February 29th, 2024]
- COVID-19 may have small but lasting effects on cognition and memory | Imperial News - Imperial College London - February 29th, 2024 [February 29th, 2024]
- More free home COVID-19 tests available from US government - WCVB Boston - November 20th, 2023 [November 20th, 2023]
- Seniors made up 63 percent of covid hospitalizations earlier this year - The Washington Post - November 20th, 2023 [November 20th, 2023]
- Fifth Covid-19 wave sees biggest bump in virus detection since ... - New Zealand Herald - November 20th, 2023 [November 20th, 2023]
- KFF COVID-19 Vaccine Monitor November 2023: With COVID ... - KFF - November 20th, 2023 [November 20th, 2023]
- What to Know About the New Dominant Covid Variant - The New York Times - August 12th, 2023 [August 12th, 2023]
- Should You Get Another Covid Booster Now, or Wait Until the Fall? - The New York Times - August 12th, 2023 [August 12th, 2023]
- A 'mini cyclone' helps detect coronavirus in the air - Science News Explores - August 12th, 2023 [August 12th, 2023]
- Infection prevention and control in the context of coronavirus ... - World Health Organization - August 12th, 2023 [August 12th, 2023]
- Serum ferritin level during hospitalization is associated with Brain ... - Nature.com - August 12th, 2023 [August 12th, 2023]
- Rhode Island Man Sentenced to Three Years in Prison for Theft and ... - Department of Justice - August 12th, 2023 [August 12th, 2023]
- Posts Exaggerate Significance of Swiss Study on Heart Risk and ... - FactCheck.org - August 12th, 2023 [August 12th, 2023]
- Wenstrup Presses Department of Education for Answers on Misuse ... - House Committee on Oversight and Reform | - August 12th, 2023 [August 12th, 2023]
- Biden Administration Fails to Share Intel on COVID-19 Origins, but Independent Evidence Is Piling Up - Heritage.org - June 24th, 2023 [June 24th, 2023]
- Do I need a booster vaccine if I recently had COVID? What if I'm not sure what I had? - The Conversation - June 24th, 2023 [June 24th, 2023]
- Psychics, wrestlers and churches: How online shopping and Covid changed mall tenants - Buffalo News - June 24th, 2023 [June 24th, 2023]
- Report: Incarcerated populations up 4% post-COVID - CorrectionsOne - June 24th, 2023 [June 24th, 2023]
- The National Average for Gross Revenue at ECP Locations Decreased for the Week of June 12 18, Jobson's Latest ... - Vision Monday - June 24th, 2023 [June 24th, 2023]
- ODNI Releases Report on the Potential Links Between the Wuhan ... - Office of the Director of National Intelligence - June 24th, 2023 [June 24th, 2023]
- U.S. Intelligence Agencies May Never Find Covid's Origins, Officials ... - The New York Times - June 24th, 2023 [June 24th, 2023]
- Covid-19 likely came from lab leak, says news report citing US energy ... - March 4th, 2023 [March 4th, 2023]
- Classified Energy Department report finds lab leak likely cause of ... - March 4th, 2023 [March 4th, 2023]
- Mayor Kirk Watson tests positive for COVID-19 - KEYE TV CBS Austin - February 5th, 2023 [February 5th, 2023]
- Biden's plan for ending the emergency declaration for COVID-19 signals a pivotal point in the pandemic 4 questions answered - The Conversation... - February 5th, 2023 [February 5th, 2023]
- Study finds one habit can significantly lower your odds of getting sick from COVID-19 - KATU - February 5th, 2023 [February 5th, 2023]
- How will life change once the COVID-19 emergency ends? - KFOX El Paso - February 5th, 2023 [February 5th, 2023]
- Shipping Corporation of India and Seven Islands Shipping re-join membership of INSA - ETInfra.com - January 30th, 2023 [January 30th, 2023]
- COVID-19 Response | United Nations - December 28th, 2022 [December 28th, 2022]
- Top German virologist says COVID-19 pandemic is over - Hindustan Times - December 28th, 2022 [December 28th, 2022]
- China says impossible to track COVID spread as virus surges - Al Jazeera English - December 14th, 2022 [December 14th, 2022]
- What are the most common COVID symptoms now? Its no longer fever, loss of taste - AL.com - December 14th, 2022 [December 14th, 2022]
- Entropy and life - Wikipedia - November 27th, 2022 [November 27th, 2022]
- Negentropy - Wikipedia - November 27th, 2022 [November 27th, 2022]
- Coronavirus: OC reported 1,602 new cases and six more deaths over the past week, as of Nov. 17 - OCRegister - November 19th, 2022 [November 19th, 2022]
- How COVID-19 damages lungs: The virus attacks mitochondria, continuing an ancient battle that began in the primordial soup - The Conversation - October 30th, 2022 [October 30th, 2022]
- How to save this winter on heating costs - WKYC.com - October 23rd, 2022 [October 23rd, 2022]
- 'Fonseca' book review: The Goan artist's biography misses the art of the matter - The New Indian Express - October 23rd, 2022 [October 23rd, 2022]
- Researchers' tests of lab-made version of Covid virus draw scrutiny - STAT - October 21st, 2022 [October 21st, 2022]
- Coronavirus: Orange County reported 1,427 more cases and seven more deaths in the past week as of Oct. 20 - OCRegister - October 21st, 2022 [October 21st, 2022]
- 3 Illinois Counties at High Community Level for COVID-19 as 1 Million Bivalent Booster Shots Have Been Administered - NBC Chicago - October 21st, 2022 [October 21st, 2022]
- What Is Coronavirus? | Johns Hopkins Medicine - October 17th, 2022 [October 17th, 2022]
- Gaston County reported 177 additional COVID-19 cases this week - Gaston Gazette - October 17th, 2022 [October 17th, 2022]
- Coronavirus Roundup: The Biden Administration Renews the Public Health Emergency for COVID-19 - GovExec.com - October 17th, 2022 [October 17th, 2022]
- Circulation of Public Warning Alert on COVID-19 vaccines fraudulently using PAHO's name and logo - World - ReliefWeb - October 17th, 2022 [October 17th, 2022]
- Time to Get Your Flu Shot and Your COVID-19 Booster Too - Health.mil - October 17th, 2022 [October 17th, 2022]
- Evasive COVID-19 subvariants that you dont know about are spreading fast - Poynter - October 17th, 2022 [October 17th, 2022]
- Deer and mink can harbor Covid-19: Why animal virologists say we need to worry - Inverse - October 17th, 2022 [October 17th, 2022]
- Europe likely entering another COVID wave, says WHO and ECDC - Reuters - October 17th, 2022 [October 17th, 2022]
- Without a nasal vaccine, the U.S. edge in fighting Covid is on the line - POLITICO - October 17th, 2022 [October 17th, 2022]
- COVID-19 Daily Update 10-17-2022 - West Virginia Department of Health and Human Resources - October 17th, 2022 [October 17th, 2022]
- Coronavirus: Government seeking to extend powers behind COVID restrictions until 2025 - Newshub - October 17th, 2022 [October 17th, 2022]
- Shocking: EcoHealth Alliance receives another round of funding for coronavirus bat research in Asia - The Center Square - October 17th, 2022 [October 17th, 2022]
- Opportunities in Health Education in the Post-COVID-19 Era: Transforming Viral to Vital - Cureus - October 17th, 2022 [October 17th, 2022]
- Fauci says COVID-19 was politicized by triple whammy of outbreak, division and 2020 election - WJTV - October 17th, 2022 [October 17th, 2022]
- How long does immunity from the new COVID bivalent boosters last 'in the real world'? - San Francisco Chronicle - October 17th, 2022 [October 17th, 2022]
- Respiratory illnesses have spiked among children. Here's what parents need to know. - Yahoo News - October 17th, 2022 [October 17th, 2022]